Sinil Pharmaceutical Co. Ltd Working Capital to Net Assets Ratio
Sinil Pharmaceutical Co. Ltd working capital to net assets ratio. Sinil Pharmaceutical Co. Ltd (012790) has a Working Capital to Net Assets ratio of 44.9% as of September 2025. Working capital of ₩68.05 Billion (current assets of ₩82.76 Billion minus current liabilities of ₩14.71 Billion) is measured against net assets of ₩151.71 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check 012790 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Sinil Pharmaceutical Co. Ltd (2014–2024)
Working capital to net assets ratio of Sinil Pharmaceutical Co. Ltd from 2014 to 2024. This chart shows how Sinil Pharmaceutical Co. Ltd's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the ratio stands at 44.9%, reflecting working capital of ₩68.05 Billion against net assets of ₩151.71 Billion KRW. See defensive interval ratio of Sinil Pharmaceutical Co. Ltd to measure how many days the company can operate on defensive assets alone.
Sinil Pharmaceutical Co. Ltd Working Capital to Net Assets Ratio by Year (2014–2024)
Sinil Pharmaceutical Co. Ltd working capital to net assets ratio by year from 2014 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Sinil Pharmaceutical Co. Ltd from 2014 to 2024, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Sinil Pharmaceutical Co. Ltd balance sheet assets.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 41.6% | ₩61.00 Billion | ₩146.51 Billion | ₩77.45 Billion | ₩16.45 Billion | ▲ +1.1 pp |
| 2023 | 40.5% | ₩54.64 Billion | ₩134.90 Billion | ₩68.79 Billion | ₩14.14 Billion | ▼ -1.1 pp |
| 2022 | 41.6% | ₩51.32 Billion | ₩123.28 Billion | ₩67.28 Billion | ₩15.96 Billion | ▲ +0.6 pp |
| 2021 | 41.0% | ₩46.40 Billion | ₩113.20 Billion | ₩58.43 Billion | ₩12.02 Billion | ▲ +1.6 pp |
| 2020 | 39.4% | ₩42.39 Billion | ₩107.48 Billion | ₩52.77 Billion | ₩10.39 Billion | ▲ +0.3 pp |
| 2019 | 39.1% | ₩39.59 Billion | ₩101.24 Billion | ₩50.67 Billion | ₩11.08 Billion | ▼ -2.5 pp |
| 2018 | 41.6% | ₩39.62 Billion | ₩95.18 Billion | ₩47.02 Billion | ₩7.40 Billion | ▼ -1.7 pp |
| 2017 | 43.3% | ₩39.37 Billion | ₩90.93 Billion | ₩47.64 Billion | ₩8.27 Billion | ▼ -8.9 pp |
| 2016 | 52.2% | ₩45.54 Billion | ₩87.19 Billion | ₩53.41 Billion | ₩7.87 Billion | ▲ +2.6 pp |
| 2015 | 49.7% | ₩38.81 Billion | ₩78.17 Billion | ₩45.83 Billion | ₩7.02 Billion | ▼ -2.6 pp |
| 2014 | 52.2% | ₩37.02 Billion | ₩70.85 Billion | ₩45.22 Billion | ₩8.20 Billion | — |